Xi Shi

Company: Takeda

Job title: Associate Director, Platform Design & Genetic Engineering, Oncology Cell Therapies

Seminars:

Panel:Reviewing Methods to Editing iPSCs to Increase Therapy Persistence & Cell Retention in vivo 1:30 pm

Discussing how to increase cell survival to produce effective regenerative cell replacement therapies Assessing methods to ensure iPSC therapies for immunology persist long enough for effective tumor killing Does administration of the cell therapy affect retention in the body?Read more

day: Day 1 Track 1 AM